Quick Answer
IDEAYA Biosciences, Inc. reported Operating Income Loss of -$159.31 million for the year ending 2025.
- IDEAYA Biosciences, Inc. showed an increase of +51.3% in Operating Income Loss from 2024 to 2025.
- This data is from IDEAYA Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), IDEAYA Biosciences, Inc.'s Operating Income Loss has declined by 1,003.4%.
- Historical annual values: Fiscal year 2025: -$159.31 million | Fiscal year 2024: -$326.98 million | Fiscal year 2023: -$134.43 million | Fiscal year 2022: -$62.50 million | Fiscal year 2021: -$50.27 million | Fiscal year 2020: -$35.34 million | Fiscal year 2019: -$44.27 million | Fiscal year 2018: -$36.42 million | Fiscal year 2017: -$14.44 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: